Comparative Analysis of Sociodemographic, Clinical Features, Laboratory Findings, and Treatment Protocols in Generalized and Localized Cutaneous Lichen Planus
- PMID: 40104468
- PMCID: PMC11915474
- DOI: 10.7759/cureus.79081
Comparative Analysis of Sociodemographic, Clinical Features, Laboratory Findings, and Treatment Protocols in Generalized and Localized Cutaneous Lichen Planus
Abstract
Background: Lichen planus (LP) is a chronic, inflammatory, and mucocutaneous disease that can present in various clinical forms, affecting the skin, mucosa, and appendages of the skin. A more extensive form of cutaneous LP, known as generalized cutaneous LP (GCLP), involves a significant portion of the body surface area. Because of the accompanying intense pruritus and difficulties with its treatment, the diagnosis and treatment of GCLP are gaining importance. In this study, we aimed to compare the characteristics of cutaneous LP with localized involvement and those of GCLP.
Methods: We retrospectively analyzed patients' sociodemographic characteristics (age, gender), clinical features (localization and duration of lesions), laboratory findings, treatments received, and relapse rates following treatment using electronic medical records obtained from our university's digital registry system.
Results: Among the patients with cutaneous LP, 24.7% (n=46) had localized cutaneous LP (LCLP), and 22.5% (n=42) had GCLP. Involvement of the trunk and flexural regions was higher among the patients with GCLP than LCLP (p<0.001 and p=0.012, respectively). Hypertriglyceridemia and hepatitis B core antibody positivity were also observed more frequently in the patients with generalized than LCLP (p=0.005 and p=0.016, respectively). Narrowband ultraviolet B and acitretin were more effective in treating patients with GCLP (p<0.001 and p=0.001, respectively). When the relapse rates in both LP groups were compared, relapses were more frequent in the patients with GCLP (p=0.022). Conclusions: The lesion localization, treatment needs, and relapse rates of patients with GCLP differ from those of patients with LCLP. This article was previously presented as an e-poster at the 32nd National Turkish Dermatology Congress on November 24, 2024.
Keywords: acitretin; classic lichen planus; cutaneous lichen planus; generalized lichen planus; hepatitis b & c.
Copyright © 2025, Urun et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Local Ethics Committee of Trakya University Faculty of Medicine issued approval 07/07. The study was approved by the Local Ethics Committee of Trakya University Faculty of Medicine (approval number: 07/07, date:15.03.2024). Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures


Similar articles
-
Acitretin for the management of generalized cutaneous lichen planus.Dermatol Online J. 2014 Sep 16;20(9):13030/qt2m36z4jm. Dermatol Online J. 2014. PMID: 25244164
-
Analysis of Coexistence of Oral and Cutaneous Lesions in 253 Patients with Lichen Planus - Single-center Retrospective Analysis.Acta Dermatovenerol Croat. 2021 Apr;291(1):1-7. Acta Dermatovenerol Croat. 2021. PMID: 34477057
-
Lichen planus associated with hepatitis C virus: no viral transcripts are found in the lichen planus, and effective therapy for hepatitis C virus does not clear lichen planus.J Am Acad Dermatol. 2003 Nov;49(5):847-52. doi: 10.1016/s0190-9622(03)02089-9. J Am Acad Dermatol. 2003. PMID: 14576663
-
Treatment of cutaneous lichen planus: an evidence based analysis of efficacy by the Italian Group for Cutaneous Immunopathology.G Ital Dermatol Venereol. 2014 Dec;149(6):719-26. G Ital Dermatol Venereol. 2014. PMID: 25664824 Review.
-
Pediatric lichen planus: A single-center retrospective review of 26 patients with follow up.Pediatr Dermatol. 2023 Jan;40(1):84-89. doi: 10.1111/pde.15170. Epub 2022 Nov 13. Pediatr Dermatol. 2023. PMID: 36373243 Review.
Cited by
-
Efficacy of Dupilumab in a Young Woman with Refractory Cutaneous Lichen Planus: A Case-Based Review.Diseases. 2025 Jul 18;13(7):225. doi: 10.3390/diseases13070225. Diseases. 2025. PMID: 40710015 Free PMC article. Review.
References
-
- A clinicopathological study of cutaneous lichen planus. Parihar A, Sharma S, Bhattacharya SN, Singh UR. Jr Derm Derm Sur. 2015;19:21–26.
-
- Epidemiology, clinical features, and associated factors in 78 cases of lichen planus on black skin. Diop A, Ly F, Ndiaye MT, et al. Int J Dermatol. 2020;59:137–142. - PubMed
-
- Lichen planus - a clinical guide. Solimani F, Forchhammer S, Schloegl A, Ghoreschi K, Meier K. J Dtsch Dermatol Ges. 2021;19:864–882. - PubMed
-
- Lichen planus: What is new in diagnosis and treatment? Tekin B, Xie F, Lehman JS. Am J Clin Dermatol. 2024;25:735–764. - PubMed
LinkOut - more resources
Full Text Sources